The invention provides a therapeutic combination comprising voriconazole and an antifungal CYP2C19 inhibitor in specific quantities and weight ratios. Pharmaceutical compositions unit dosage forms and kits comprising voriconazole and an antifungal CYP2C19 inhibitor and their use in the treatment of fungal infections are also provided.

A pharmaceutical composition is disclosed which comprises multiparticulates wherein said multiparticulates further comprise an azithromycin core and an enteric coating disposed upon said azithromycin core.

The present invention relates to new crystalline forms of syn-5-Fluoro-N-[4-(2-hydroxy-4-methyl-benzoylamino)-cyclohexyl ]-2-(tetrahydro-thiopyran-4-yloxy)-nicotinamide and to processes for the preparation of compositions containing and the uses of such crystalline forms.

A chewing gum composition including a water insoluble base portion; a water soluble portion; and a therapeutically effective amount of varenicline or its pharmaceutical acceptable salt thereof. A method for reducing nicotine addiction and aiding in the cessation or lessening of tobacco use in an individual by administering to an oral cavity of an individual a chewing gum composition including an effective amount of varenicline or its pharmaceutical acceptable salt thereof; and chewing the gum co...

THE INVENTION RELATES TO NICOTINAMIDE DERIVATIVES AND TO PROCESSES FOR THE PREPARATION OF INTERMEDIATES USED IN THE PREPARATION OF COMPOSITIONS CONTAINING AND THE USES OF SUCH DERIVATIVES.THE NICOTINAMIDE DERIVATIVES ACCORDING TO THE PRESENT INVENTION ARE USEFUL IN NUMEROUS DISEASES DISORDERS AND CONDITIONS IN PARTICULAR INFLAMMATORY ALLERGICRESPIRATORY DISEASES DISORDERS AND CONDITIONS AS WELL AS WOUNDS.

A plug-in Wi-Fi access point device and system is provided that is configured for Wi-Fi or other wireless network and to be directly plugged into a face plate/workstation. The plug-in Wi-Fi access point device and system advantageously provides ease of integration into an existing wired network without the use of a patch cord security from removal by unauthorized personnel non obtrusiveness in relation to other face plate/workstation jacks and the ability to be powered through an Ethernet connec...

This invention relates to a compound of formula (I)or pharmaceutically acceptable salts thereof pharmaceutical compositions containing the compound or a salt thereof and its use as a medicament for the treatment of schizophrenia bipolar disorder or other central nervous system disorders.

PREGABALIN COMPOSITION A chemically and physically stable orally administrable aqueous pharmaceutical composition containing pregabalin is described. The liquid composition includes at least one preservative at least one taste-masking agent and an optional viscosity control agent. The liquid pharmaceutical composition has a pH of at least 5.5 but not greater than 7.0.

A chemically and physically stable orally administrable aqueous pharmaceutical composition containing pregabalin is described.The liquid composition includes at least one preservative at least one taste- masking agent and an optional viscosity control agent.The liquid pharmaceutical composition has a pH of at least 5.5 but not greater than 7.0.(C) KIPO WIPO 2007